Formulation Development and evaluation of Fast Dissolving Tablets of Carvedilol
ABSTRACT:
Carvedilol is a poorly water soluble oral antihypertensive
agent, with problems of variable bioavailability and bioequivalence related to
its poor water solubility. Carvedilol is a nonselective beta adrenergic
blocking agent with alpha-1 blocking activity and is indicated for the
treatment of hypertension and mild to moderate heart failure of ischematic or
cardiomyopathic origin In the present work solubility was enhanced by using β-
cyclodextrin as a complexing agent. Sweeteners and flavors were used to enhance
the organoleptic properties of tablet. Solubility studies were performed to
investigate the drug carrier interaction. I.R. and D.S.C studies carried out to
investigate any interaction and stability of formulation. Tablets were prepared
by direct compression technique. Prepared tablets were evaluated for thickness,
uniformity of weight, hardness, friability, wetting time, in-vitro
disintegration time, drug content and in vitro drug release. All the
formulations were evaluated for the influence of disintegrates and their
concentrations on the characteristics of fast dissolving tablets mainly in
terms of disintegration time and dissolution studies. Optimized formulation of
Ac-Di-Sol Superdisintegrant in the concentration of (6mg) i.e. F3 batch gives
best results than all the formulation. Formulation F3 of Ac-Di-sol
superdisintegrant required minimum disintegration time, wetting time Compared
to Formulations of Crosspovidone, or Sodium-starch glycoate with same
concentration. From this study it can be concluded that Carvedilol can be
successfully complexed with Beta-cyclodextrin to prepare fast dissolving
tablets in the ratio of 1: 4.
Further details @
http://www.jocpr.com/
For more details @
http://www.jocpr.com/articles/formulation-development-and-evaluation-of-fast-dissolving-tablets-of-carvedilol.pdf
Comments
Post a Comment